Ex-KV Pharmaceutical CEO Pleads Guilty, Gets 30-Day Sentence
This article is for subscribers only.
Marc Hermelin, the former KV Pharmaceutical Co. chief executive officer banned last year from doing business with the U.S., pleaded guilty to violating drug-labeling laws and was sentenced to 30 days in prison.
U.S. District Judge E. Richard Webber in St. Louis also ordered Hermelin today to pay a $1 million fine and forfeit $900,000. Hermelin, who the Bridgeton, Missouri-based company said was fired as CEO and chairman in 2008 and who resigned as a director in November, reached a plea agreement today with prosecutors, who also announced the charges today.